HL7 Europe Hospital Discharge Report
0.1.0-ballot - draft
150
HL7 Europe Hospital Discharge Report
0.1.0-ballot - draft
150
This page is part of the HL7 Europe Hospital Discharge Report (v0.1.0-ballot: STU 1 Ballot 1) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
<Composition xmlns="http://hl7.org/fhir">
<id value="b9dc409d-ec81-4556-9fac-4dc3f731c199"/>
<meta>
<profile
value="http://hl7.eu/fhir/hdr/StructureDefinition/composition-eu-hdr"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: Composition b9dc409d-ec81-4556-9fac-4dc3f731c199</b></p><a name="b9dc409d-ec81-4556-9fac-4dc3f731c199"> </a><a name="hcb9dc409d-ec81-4556-9fac-4dc3f731c199"> </a><a name="b9dc409d-ec81-4556-9fac-4dc3f731c199-en-US"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-composition-eu-hdr.html">Composition (HDR)</a></p></div><p><b>status</b>: Final</p><p><b>type</b>: <span title="Codes:{http://loinc.org 34105-7}">Hospital Discharge summary</span></p><p><b>encounter</b>: <a href="Bundle-HDR-Luigi-De-Luca-Example.html#urn-uuid-7c9a2bf1-507f-4d43-b06e-d78e9670379d">Bundle: identifier = Provider number; type = document; timestamp = 2025-04-29 14:00:00+0000</a></p><p><b>date</b>: 2025-04-29 13:30:00+0100</p><p><b>author</b>: <a href="Bundle-HDR-Luigi-De-Luca-Example.html#urn-uuid-74403dd8-bb1b-45f9-bb69-e843dfaf45e9">Bundle: identifier = Provider number; type = document; timestamp = 2025-04-29 14:00:00+0000</a></p><p><b>title</b>: Hospital Discharge Report</p><p><b>custodian</b>: <a href="Bundle-HDR-Luigi-De-Luca-Example.html#urn-uuid-a61a91f8-b8f2-4947-9a64-5165ea380a38">Bundle: identifier = Provider number; type = document; timestamp = 2025-04-29 14:00:00+0000</a></p></div>
</text>
<status value="final"/>
<type>
<coding>
<system value="http://loinc.org"/>
<code value="34105-7"/>
<display value="Hospital Discharge summary"/>
</coding>
</type>
<subject>
<reference value="urn:uuid:b01a2623-e219-41d2-8e78-1fa1439751d0"/>
</subject>
<encounter>
<reference value="urn:uuid:7c9a2bf1-507f-4d43-b06e-d78e9670379d"/>
</encounter>
<date value="2025-04-29T13:30:00+01:00"/>
<author>
<reference value="urn:uuid:74403dd8-bb1b-45f9-bb69-e843dfaf45e9"/>
</author>
<title value="Hospital Discharge Report"/>
<custodian>
<reference value="urn:uuid:a61a91f8-b8f2-4947-9a64-5165ea380a38"/>
</custodian>
<section>
<title value="Admission evaluation"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="67851-6"/>
</coding>
<coding>
<system value="http://loinc.org"/>
<code value="67852-4"/>
<display value="Hospital Admission evaluation note"/>
</coding>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml">Mr. Luigi De Luca, a 57-year-old male, was admitted on 1st April following a pre-diabetic episode characterized by episodes of fatigue, polyuria, and increased thirst. Recent routine blood tests showed elevated fasting blood glucose and HbA1c levels that required further investigation.<p/>When Mr De Luca arrived in the morning we recorded a fasting blood glucose level at 180 mg/dL. His HbA1c level was 7.8%. He seemed to be dehydrated, so that he immediately was sent to the ward for a full breakfast and fluid substitution.</div>
</text>
</section>
<section>
<title value="Family History"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="10157-6"/>
<display value="History of family member diseases Narrative"/>
</coding>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml">Mr. Luigi has a family history of diabetes (type 2, mother and maternal grandmother).</div>
</text>
<entry>
<reference value="urn:uuid:635c22e7-d7f1-45ad-9b4d-d4fe35239085"/>
</entry>
<entry>
<reference value="urn:uuid:3fbdfbe1-9d70-47ec-ac05-3e30b063365a"/>
</entry>
</section>
<section>
<title value="Vital signs"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="8716-3"/>
<display value="Vital signs"/>
</coding>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml"><table class="hl7__hdr"><thead><tr><th>Vital signs</th><th>1st April</th><th>10th April</th></tr></thead><tbody><tr><td>Body weight</td><td>109 kg</td><td>108 kg</td></tr><tr><td>Body height</td><td>177 cm</td><td/></tr><tr><td>Blood Pressure</td><td>155 / 95 mmHg</td><td>150 / 90 mmHg</td></tr></tbody></table></div>
</text>
<entry>
<reference value="urn:uuid:f0113857-b9b7-429b-8893-b645a38ae20a"/>
</entry>
<entry>
<reference value="urn:uuid:065c918f-730a-47f8-938a-7ad54618037b"/>
</entry>
<entry>
<reference value="urn:uuid:81783ae4-c36d-424f-8cea-fe7d3407a36b"/>
</entry>
<entry>
<reference value="urn:uuid:a19e48e1-2271-4cdb-9c76-b0626c7a5363"/>
</entry>
<entry>
<reference value="urn:uuid:fd7f7580-5788-45dd-88ec-dca615d69c7d"/>
</entry>
</section>
<section>
<title value="Tobacco use"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="11367-0"/>
<display value="History of Tobacco use"/>
</coding>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml">The patient smokes "a few" cigarettes per day.</div>
</text>
<entry>
<reference value="urn:uuid:67152b1b-0ffa-4b8f-8b6a-a3d71d4d58b6"/>
</entry>
</section>
<section>
<title value="Hospital Course"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="8648-8"/>
<display value="Hospital Course"/>
</coding>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml">During the hospital stay from 1 to 10 April, Mr. De Luca underwent a series of diagnostic tests, consultations and initial treatment.<p/>Throughout his hospital stay, Mr. De Luca was monitored closely. His blood sugar levels improved modestly with the introduction of Metformin, and no acute complications were observed.</div>
</text>
</section>
<section>
<title value="Significant Observation Results"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="30954-2"/>
<display value="Relevant diagnostic tests/laboratory data Narrative"/>
</coding>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml">Blood Glucose Monitoring Regular monitoring of fasting blood glucose levels and random blood glucose levels. Fasting glucose levels consistently ranged between 140-180 mg/dL.<table class="hl7__hdr"><thead><tr><th>Date</th><th>Fasting glucose [Moles/volume] in Blood</th><th>Range</th></tr></thead><tbody><tr><td>1 April 2025</td><td>180 mg/dL</td><td>70 to 99 mg/dL</td></tr><tr><td>2 April 2025</td><td>140 mg/dL</td><td>70 to 99 mg/dL</td></tr><tr><td>3 April 2025</td><td>150 mg/dL</td><td>70 to 99 mg/dL</td></tr><tr><td>5 April 2025</td><td>140 mg/dL</td><td>70 to 99 mg/dL</td></tr></tbody></table>HbA1c Test: An HbA1c level of 7.2%, confirming the diagnosis of Type 2 Diabetes Mellitus.<table class="hl7__hdr"><thead><tr><th>Date</th><th>Hemoglobin A1c [Mass/volume] in Blood</th><th>Range</th></tr></thead><tbody><tr><td>1 April 2025</td><td>7.2%</td><td>< 5.7%</td></tr></tbody></table>Oral Glucose Tolerance Test (OGTT): This test further confirmed impaired glucose tolerance.<table class="hl7__hdr"><thead><tr><th>Date</th><th>Glucose [Mass/volume] in Serum or Plasma --1 hour post dose glucose</th><th>Range</th></tr></thead><tbody><tr><td>2 April 2025</td><td>180 mg/dL</td><td>70 to 99 mg/dL</td></tr></tbody></table></div>
</text>
</section>
<section>
<title value="Significant procedures"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="10185-7"/>
<display value="Hospital discharge procedures Narrative"/>
</coding>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml">Lifestyle Consultation: Mr. De Luca met with a dietitian to discuss necessary changes in his diet, focusing on a low glycemic index diet and the need to monitor carbohydrate intake. He was also advised to engage in regular physical activity.<p/>Diabetes Education: Mr. De Luca attended educational sessions on diabetes management, including the importance of regular blood sugar monitoring, recognizing hypoglycemia and hyperglycemia symptoms, and foot care.<p/>Starting Pharmacotherapy with Metformin.</div>
</text>
<entry>
<reference value="urn:uuid:92ffc1fd-71ff-4d54-bc06-25d9e1e1fea0"/>
</entry>
<entry>
<reference value="urn:uuid:a74a3dca-92fa-4b71-8e70-89a07ac74bc3"/>
</entry>
<entry>
<reference value="urn:uuid:53a8c3c3-5d1b-4950-87bc-fddae2ebc079"/>
</entry>
</section>
<section>
<title value="Medications"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="87232-5"/>
<display value="Medication administration.brief"/>
</coding>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml">Metformin 500 mg twice daily was started as the first-line treatment to help control blood glucose levels.<table class="hl7__hdr"><thead><tr><th>Medication administrations</th><th>Dose/Frequency</th><th>SNOMED</th></tr></thead><tbody><tr><td>Metformin, oral tbl</td><td>500 mg, twice / day</td><td>765507008</td></tr><tr><td>Multivitamines</td><td>daily</td><td/></tr></tbody></table></div>
</text>
<entry>
<reference value="urn:uuid:bda0b497-c9f2-47ca-8339-da1d379cb2f4"/>
</entry>
</section>
<section>
<title value="Follow-up"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="18776-5"/>
<display value="Plan of care note"/>
</coding>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml"><table class="hl7__hdr"><thead><tr><th>Follow-up</th><th>Activity</th><th>SNOMED</th></tr></thead><tbody><tr><td>Endocrinology Clinic</td><td>Follow-up appointment in 2 weeks to assess response to treatment</td><td>306118006 Referral to endocrinology service (procedure)</td></tr><tr><td>Dietitian Consultation</td><td>Appointment in 1 month for further dietary planning</td><td>103699006 Referral to dietitian (procedure)</td></tr><tr><td>Routine Blood tests</td><td>Repeat HbA1c in 3 months</td><td>43396009 Hemoglobin A1c measurement (procedure)</td></tr></tbody></table></div>
</text>
<entry>
<reference value="urn:uuid:b84038f8-9541-4c5b-93b0-a7f1b8e55bd3"/>
</entry>
</section>
<section>
<title value="Diagnosis at Discharge"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="11535-2"/>
<display value="Hospital discharge Dx Narrative"/>
</coding>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml"><table class="hl7__hdr"><thead><tr><th>Discharge Diagnoses</th><th>Codes</th></tr></thead><tbody><tr><td>Type 2 Diabetes Mellitus – Newly diagnosed.</td><td><ul><li>Type 2 diabetes mellitus E11 (ICD-10)</li><li>Diabetes mellitus type 2 (disorder) 44054006 (SNOMED)</li></ul></td></tr></tbody></table></div>
</text>
<entry>
<reference value="urn:uuid:a5bf69e4-24db-48a8-9eda-71516dcaf1d9"/>
</entry>
</section>
<section>
<title value="Hospital Discharge Instructions"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="8653-8"/>
<display value="Hospital Discharge Instructions"/>
</coding>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml">Instructions at Discharge to Mr. De Luca<ul><li>Continue home glucose monitoring and to maintain a log for review at follow-up appointments.</li><li>Continue with the prescribed medication and lifestyle changes.</li><li>Monitor blood sugar levels at home regularly.</li><li>Adhere to the diabetic diet plan.</li><li>Stay physically active, with at least 30 minutes of moderate exercise most days of the week.</li><li>Return to the emergency department for any signs of hyperglycemia (e.g., excessive thirst, urination, confusion) or hypoglycemia (e.g., sweating, shakiness, confusion).</li></ul></div>
</text>
</section>
</Composition>
IG © 2024+ HL7 Europe. Package hl7.fhir.eu.hdr#0.1.0-ballot based on FHIR 4.0.1. Generated 2025-06-03
